Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson purchased 222 shares of the stock in a transaction that occurred on Monday, January 13th. The stock was purchased at an average cost of GBX 68 ($0.83) per share, with a total value of £150.96 ($184.77).
Giles Wilson also recently made the following trade(s):
- On Monday, November 11th, Giles Wilson purchased 263 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 57 ($0.70) per share, with a total value of £149.91 ($183.49).
Dr. Martens Trading Up 3.5 %
Shares of LON DOCS opened at GBX 67.90 ($0.83) on Thursday. The stock has a market cap of £653.01 million, a price-to-earnings ratio of 970.00, a PEG ratio of 6.40 and a beta of 0.11. The business has a 50 day simple moving average of GBX 67.32 and a 200 day simple moving average of GBX 65.77. Dr. Martens plc has a 52 week low of GBX 49.32 ($0.60) and a 52 week high of GBX 100 ($1.22). The company has a debt-to-equity ratio of 129.55, a quick ratio of 1.13 and a current ratio of 2.85.
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
- Five stocks we like better than Dr. Martens
- Are Penny Stocks a Good Fit for Your Portfolio?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- How to Calculate Return on Investment (ROI)
- How Do Stock Buybacks Affect Shareholders?
- Short Selling – The Pros and Cons
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.